PF-06679142

Modify Date: 2024-09-17 10:07:21

PF-06679142 Structure
PF-06679142 structure
Common Name PF-06679142
CAS Number 1467059-66-0 Molecular Weight 357.357
Density N/A Boiling Point N/A
Molecular Formula C20H17F2NO3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of PF-06679142


PF-06679142 is a novel potent, orally active, α1β1γ1/α2β1γ1-isoform selective AMPK activator with Kd of 14 nM, EC50 of 22 nM for α1β1γ1-AMPK, shows minimal activity at the β2-containing isoforms (α1β2γ1, α2β2γ1, α2β2γ3); demonstrates in vivo target engagement experiment in ZSF-1 rats, an obese/diabetic rodent model of diabetic nephropathy.

 Names

Name PF-06679142

 PF-06679142 Biological Activity

Description PF-06679142 is a novel potent, orally active, α1β1γ1/α2β1γ1-isoform selective AMPK activator with Kd of 14 nM, EC50 of 22 nM for α1β1γ1-AMPK, shows minimal activity at the β2-containing isoforms (α1β2γ1, α2β2γ1, α2β2γ3); demonstrates in vivo target engagement experiment in ZSF-1 rats, an obese/diabetic rodent model of diabetic nephropathy.
References References 1. Edmonds DJ, et al. J Med Chem. 2018 Feb 28. doi: 10.1021/acs.jmedchem.7b01641. View Related Products by Target AMPK

 Chemical & Physical Properties

Molecular Formula C20H17F2NO3
Molecular Weight 357.357
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

PF-06679142 suppliers

PF-06679142 price

Related Compounds: More...
PF-06471553
1808094-07-6
PF-05085727
1415637-72-7
PF-03463275
1173177-11-1
PF-06815189
2218484-75-2
PF-06869206
2227425-05-8
PF 945863
893556-85-9
PF-06952229
1801333-55-0
PF-04531083
1079400-07-9
PF-06726304 acetate
2080306-28-9
2-benzyl-N1-[1-{[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]amino}-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-N4-(2-methoxyethyl)-N4-methylbutanediamide
127944-51-8
O-methyl-N-(morpholin-4-ylcarbonyl)tyrosyl-N-[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]histidinamide
127944-48-3
2-benzyl-N1-[1-{[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]amino}-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-N4-[2-(methoxymethoxy)ethyl]-N4-methylbutanediamide
127944-53-0
N-[(3,4-dihydroxypyrrolidin-1-yl)carbonyl]-O-methyltyrosyl-N-[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]histidinamide
127944-49-4
N-[(2,3-dihydroxypropyl)(methyl)carbamoyl]-O-methyltyrosyl-N-[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]histidinamide
127944-50-7
(4R)-5-Cyclohexyl-2,2-difluoro-4-[[(2S)-2-[[(2S)-2-[(4-methylpiperazin-1-yl)sulfonylamino]-3-phenylpropanoyl]amino]pent-4-enoyl]amino]-N-(2-morpholin-4-ylethyl)-3-oxopentanamide
137429-62-0
L-Phenylalaninamide, 1-acetyl-N-[(octahydro-1,4-dioxo-6,9-ethano-2H-pyrido[1,2-a]pyrazin-3-yl)acetyl]-D-tryptophyl-N-methyl-N-(phenylmethyl)-, (3S-trans)-
149151-29-1
L-Phenylalaninamide, 1-(methoxycarbonyl)-N-[(octahydro-1,4-dioxo-6,9-ethano-2H-pyrido[1,2-a]pyrazin-3-yl)acetyl]-D-tryptophyl-N-methyl-N-(phenylmethyl)-, (3S-trans)-
149151-30-4
Na-{2-benzyl-4-[3,4-bis(methoxymethoxy)pyrrolidin-1-yl]-4-oxobutanoyl}-N-[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]histidinamide
122224-83-3
N-[{2-[(2-methoxyethoxy)methoxy]ethyl}(methyl)carbamoyl]-O-methyltyrosyl-N-[3-cyclohexyl-1-(3-ethyl-2-oxo-1,3-oxazolidin-5-yl)-1-hydroxypropan-2-yl]histidinamide
127944-54-1